Internet-based vestibular rehabilitation for older dizzy adults: does it work? A single blind, three arm, randomised controlled trial in general practice

Internet-based vestibular rehabilitation for older dizzy adults: does it work? A single blind, three arm, randomised controlled trial in general practice - VERTIGO

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON42858

Enrollment

300

Registered

2016-11-09

Start date

2017-06-12

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertigo/dizziness

Interventions

Patients in the first trial arm will receive stand-alone internet-based VR. This intervention is a translated Dutch version of the British intervention that showed to be safe and effective. The inte

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - being 50 years or older - having access to internet and an email account - having consulted a general practitioner for dizziness in the last two years, defined as recurrent dizziness for at least one month, including a giddy or rotational sensation, loss of balance, faint feeling, light-headedness, instability, or tendency to fall - being able to speak, read and write Dutch - still experiencing dizziness at time of inclusion - head movements increase the dizziness (otherwise it is unlikely that the dizziness is of vestibular origin and therefore unlikely to respond to VR).

Exclusion criteria

Exclusion criteria: - An identifiable non-vestibular cause of dizziness in the electronic record of the patient - Medical contraindications for making the required head movements (for example, severe cervical arthrosis). - Serious comorbid conditions that preclude participation in an exercise programme. - Current enrolment in another * interfering * study.

Design outcomes

Primary

Measure	Time frame
The primary outcome, dizziness symptoms at 6 months, will be assessed using the Vertigo Symptoms Scale-Short Form.	—

Secondary

Measure	Time frame
Secondary outcome measures will be dizziness-related impairment (Dizziness Handicap Inventory), subjective improvement in dizziness symptoms, anxiety and depression (Patient Health Questionnaire), quality of life (EQ-5D-5L) and adherence to treatment (Problematic Experiences of Therapy Scale). Costs will be measured from a societal perspective using the iMTA Medical Consumption and Productivity Cost questionnaires (iMCQ and iPCQ). Also, we will investigate predictors of successful treatment with internet-based VR (with and without physiotherapeutic support), and investigate patients* experiences with semi-structured face-to-face interviews to analyse patients* perceptions on the intervention and difficulties/practical barriers that they faced.	—

Measure

Time frame

Secondary outcome measures will be dizziness-related impairment (Dizziness Handicap Inventory), subjective improvement in dizziness symptoms, anxiety and depression (Patient Health Questionnaire), quality of life (EQ-5D-5L) and adherence to treatment (Problematic Experiences of Therapy Scale). Costs will be measured from a societal perspective using the iMTA Medical Consumption and Productivity Cost questionnaires (iMCQ and iPCQ). Also, we will investigate predictors of successful treatment with internet-based VR (with and without physiotherapeutic support), and investigate patients* experiences with semi-structured face-to-face interviews to analyse patients* perceptions on the intervention and difficulties/practical barriers that they faced.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)